Adding daratumumab to VRd shows better efficacy outcomes compared to VRd alone in multiple myeloma

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituximab therapy

Significant clinical benefits observed with revumenib monotherapy in relapsed/refractory KMT2Ar acute leukaemia

Ide-cell enhances health-related quality of life for refractory multiple myeloma

Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B-cell lymphoma

Beat AML master trial: A clinical trial for acute myeloid leukaemia

BrECADD combined with PET2-guided treatment sets a new benchmark for the treatment of newly diagnosed advanced-stage cHL

Ponatinib is superior to imatinib in combination with chemotherapy for newly diagnosed Ph+ ALL